Sorry, you need to enable JavaScript to visit this website.
Skip to main content


Moxifloxacin Hydrochloride

Therapeutic Category
Anti-Infective
API Technology
Synthetic
Dose From
Oral Solids
Injectable
Opthalmic
Dr Reddy's Development Status
Available
Available Regulatory Filing
USA
Canada
CEP
China
Saudi Arabia
Taiwan
Russia
Brazil
Innovator Brand (USA)
AVELOX

We are here to help, if you have any country specific requirements - please Contact Us.